BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang XH, Nam S, Wu J, Chen CH, Liu X, Li H, McKeithan T, Gong Q, Chan WC, Yin HH, Yuan YC, Pillai R, Querfeld C, Horne D, Chen Y, Rosen ST. Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma. J Invest Dermatol 2018;138:2377-87. [PMID: 29758280 DOI: 10.1016/j.jid.2018.04.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Bresin A, Caprini E, Russo G, Narducci MG. Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far. J Invest Dermatol 2022:S0022-202X(21)02615-4. [PMID: 35000751 DOI: 10.1016/j.jid.2021.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xu W, Liu R, Dai Y, Hong S, Dong H, Wang H. The Role of p38γ in Cancer: From review to outlook. Int J Biol Sci 2021;17:4036-46. [PMID: 34671218 DOI: 10.7150/ijbs.63537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
3 Zhang XH, Chen CH, Li H, Hsiang J, Wu X, Hu W, Horne D, Nam S, Shively J, Rosen ST. Targeting the non-ATP-binding pocket of the MAP kinase p38γ mediates a novel mechanism of cytotoxicity in cutaneous T-cell lymphoma (CTCL). FEBS Lett 2021;595:2570-92. [PMID: 34455585 DOI: 10.1002/1873-3468.14186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang XH, Hsiang J, Rosen ST. Flavopiridol (Alvocidib), a Cyclin-dependent Kinases (CDKs) Inhibitor, Found Synergy Effects with Niclosamide in Cutaneous T-cell Lymphoma. J Clin Haematol 2021;2:48-61. [PMID: 34223559 DOI: 10.33696/haematology.2.028] [Reference Citation Analysis]
5 Herrera-melle L, Crespo M, Leiva M, Sabio G. Stress-activated kinases signaling pathways in cancer development. Current Opinion in Physiology 2021;19:22-31. [DOI: 10.1016/j.cophys.2020.08.005] [Reference Citation Analysis]
6 Zhang XH, Yin Z, Zhang A, Pillai R, Armstrong B, Rosen ST. DNMT1 and p38γ are inversely expressed in reactive non‐metastatic lymph nodes burdened with colorectal adenocarcinoma. eJHaem 2020;1:300-303. [DOI: 10.1002/jha2.50] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chen B, Zheng Y, Zhu J, Liang Y. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides. Exp Dermatol 2019;28:1279-88. [PMID: 31461795 DOI: 10.1111/exd.14026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ramelyte E, Dummer R, Guenova E. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update. Expert Opin Investig Drugs 2019;28:799-809. [PMID: 31398295 DOI: 10.1080/13543784.2019.1654995] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
9 Querfeld C, Zain J, Rosen ST. Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary Syndrome. In: Querfeld C, Zain J, Rosen ST, editors. T-Cell and NK-Cell Lymphomas. Cham: Springer International Publishing; 2019. pp. 225-48. [DOI: 10.1007/978-3-319-99716-2_11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]